Company intelligence / Profile preview

Cervelo Pharmaceuticals

Waltham, Massachusetts, USA
Ownership
Private
Development stage
Other
01

Overview

Cervelo Pharmaceuticals was a clinical-stage biopharmaceutical company focused on developing innovative therapies for neurological and psychiatric disorders. The company's lead program, CP-011, was an intranasal formulation of dihydroergotamine (DHE) designed for the acute treatment of cluster headaches. Founded by industry veterans from MAP Pharmaceuticals, Cervelo aimed to leverage specialized drug delivery technologies to improve the pharmacokinetic profile of established compounds. The company successfully advanced CP-011 into Phase 2 clinical trials to evaluate its efficacy and safety in patients with episodic or chronic cluster headache. However, the company has since ceased operations, and its development programs are no longer active.

Therapeutic areas
Neurology
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on Cervelo Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cervelo Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call